Center for Drug Discovery
Matching Micro Grant Program
The Center for Drug Discovery (CDD) was founded in May 2016 at Washington University in Saint Louis. CDD’s mission is to facilitate the translation of basic research into new medicines. Following the successful launch of its pilot grant program administered through the LEAP Inventor Challenge Award, the CDD is now offering a new funding mechanism in the form of matching Micro Grants to stimulate the use of the Center’s services in support of its translational drug discovery mission.
Micro Grant Program. Micro Grants are matching awards of up to $7500 to cover 50% of work performed by or managed within the CDD or the allied High-throughput Screening Core. For example, when an investigator spends $7500 on CDD services the CDD will match in kind with an additional $7500. It is expected that (1) 100% of the funds will be spent in the CDD and (2) data generated from the Micro Grant will be used to support a future CDD Grant proposal or other intramural and extramural funding opportunities and will be tracked accordingly.
Preference will be given to studies on novel drug targets including:
- Assay development for small molecule screening
- Access and screening of chemical libraries
- Identification of chemical starting points using computational techniques
- Chemical probe/lead compound synthesis and structure-activity development
- In vitro drug profiling
- In vivo pharmacokinetic/pharmacodynamic studies
- In vivo pharmacology
- Selected biologics/antibody synthesis & related research
Eligibility. The Micro Grant program is open to all faculty members at Washington University in Saint Louis.
Instructions. Proposals are accepted on a rolling basis. Please refer to the CDD website for more information and the application submission form: cdd.wustl.edu. For general inquiries, contact: email@example.com
Acknowledgement. The following acknowledgement must be used when publishing or presenting work funded by this Micro Grant program: “Funding for this project was provided in part by the Center for Drug Discovery (CDD) of Washington University Saint Louis.”